Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kenichiro Hasumi, Yukimasa Aoki, Ryuko Wantanabe & Dean L Mann. (2013) Clinical response of advanced cancer patients to cellular immunotherapy and intensity-modulated radiation therapy. OncoImmunology 2:10.
Read now
Read now
Erin L Lousberg, Kerrilyn R Diener, Michael P Brown & John D Hayball. (2011) Innate immune recognition of poxviral vaccine vectors. Expert Review of Vaccines 10:10, pages 1435-1449.
Read now
Read now
Articles from other publishers (28)
Joseph F. Murphy. 2021. Cancer Immunology. Cancer Immunology
1
23
.
Maarten Versteven, Johan M. J. Van den Bergh, Elly Marcq, Evelien L. J. Smits, Viggo F. I. Van Tendeloo, Willemijn Hobo & Eva Lion. (2018) Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer. Frontiers in Immunology 9.
Crossref
Crossref
Saroj Singh, Neesha Mehta, Jiang Lilan, Meen Bahadur Budhthoki, Fu Chao & Li Yong. (2017) Initiative action of tumor-associated macrophage during tumor metastasis. Biochimie Open 4, pages 8-18.
Crossref
Crossref
Alessandro Allegra, Giuseppa Penna, Vanessa Innao, Bruna Greve, Valerio Maisano, Sabina Russo & Caterina Musolino. (2015) Vaccination of multiple myeloma: Current strategies and future prospects. Critical Reviews in Oncology/Hematology 96:2, pages 339-354.
Crossref
Crossref
Jun Lu, Junjun Ma, Wei Cai, Xiongzhi Wangpu, Hao Feng, Jingkun Zhao, Shaopei Guan, Yaping Zong & Aiguo Lu. (2015) CC motif chemokine ligand 19 suppressed colorectal cancer in vivo accompanied by an increase in IL-12 and IFN-γ. Biomedicine & Pharmacotherapy 69, pages 374-379.
Crossref
Crossref
Joseph F. Murphy. 2015. Cancer Immunology. Cancer Immunology
1
22
.
Kim Vaiphei, Saroj Kant Sinha & Rakesh Kochhar. (2014) Comparative Analysis of Oct4 in Different Histological Subtypes of Esophageal Squamous Cell Carcinomas in Different Clinical Conditions. Asian Pacific Journal of Cancer Prevention 15:8, pages 3519-3524.
Crossref
Crossref
Brian M. Olson & Douglas G. McNeel. 2014. Engineering in Translational Medicine. Engineering in Translational Medicine
449
471
.
Yan-Xia Hu, Min Li, Xiao-Hui Jia, Qu-Xiao Du, Feng-Tai Miao, Li Yao & Ji-Duo Shen. (2013) HPV16 CTL Epitope Peptide-activated Dendritic Cell and Natural Killer Co-culture for Therapy of Cervical Cancer in an Animal Model. Asian Pacific Journal of Cancer Prevention 14:12, pages 7335-7338.
Crossref
Crossref
Jake Y. Henry, Marie‐Christine Labarthe, Brendan Meyer, Prokar Dasgupta, Angus G. Dalgleish & Christine Galustian. (2013)
Enhanced cross‐priming of naive
CD
8
+
T
cells by dendritic cells treated by the
IM
i
D
s
®
immunomodulatory compounds lenalidomide and pomalidomide
. Immunology 139:3, pages 377-385.
Crossref
Crossref
David A. Phoenix, Sarah R. Dennison & Frederick Harris. 2013. Antimicrobial Peptides. Antimicrobial Peptides
181
221
.
Frederick Harris, Sarah R. Dennison, Jaipaul Singh & David A. Phoenix. (2011) On the selectivity and efficacy of defense peptides with respect to cancer cells. Medicinal Research Reviews 33:1, pages 190-234.
Crossref
Crossref
Alexander Shimabukuro-Vornhagen, Andreas Draube, Tanja M Liebig, Achim Rothe, Matthias Kochanek & Michael S von Bergwelt-Baildon. (2012) The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells. Journal of Experimental & Clinical Cancer Research 31:1.
Crossref
Crossref
Frances Ka-Yin LinYiu-Loon Chui. (2012) Generation of Induced Pluripotent Stem Cells from Mouse Cancer Cells. Cancer Biotherapy and Radiopharmaceuticals 27:10, pages 694-700.
Crossref
Crossref
Anna-Maria A. De Costa, Danielle N. Justis, Corinne A. Schuyler & M. Rita I. Young. (2012) Administration of a vaccine composed of dendritic cells pulsed with premalignant oral lesion lysate to mice bearing carcinogen-induced premalignant oral lesions stimulates a protective immune response. International Immunopharmacology 13:3, pages 322-330.
Crossref
Crossref
Qiu Xie, Jia Luo, Zhiqiang Zhu, Guoliang Wang, Jianhua Wang & Bo Niu. (2012) Nucleofection of a DNA vaccine into human monocyte-derived dendritic cells. Cellular Immunology 276:1-2, pages 135-143.
Crossref
Crossref
J. Fitting, D. Killian, C. Junghanss, S. Willenbrock, H. Murua Escobar, S. Lange, I. Nolte, S. Barth & M. K. Tur. (2010) Generation of recombinant antibody fragments that target canine dendritic cells by phage display technology. Veterinary and Comparative Oncology 9:3, pages 183-195.
Crossref
Crossref
Norman Woller, Sarah Knocke, Bettina Mundt, Engin G?rlevik, Nina Str?ver, Arnold Kloos, Bita Boozari, Peter Schache, Michael P. Manns, Nisar P. Malek, Tim Sparwasser, Lars Zender, Thomas C. Wirth, Stefan Kubicka & Florian K?hnel. (2011) Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice. Journal of Clinical Investigation 121:7, pages 2570-2582.
Crossref
Crossref
Alan Melcher, Kelley Parato, Cliona M Rooney & John C Bell. (2011) Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide. Molecular Therapy 19:6, pages 1008-1016.
Crossref
Crossref
Kevin P Nishimoto, Su-Yi Tseng, Jane S Lebkowski & Anita Reddy. (2011) Modification of human embryonic stem cell-derived dendritic cells with mRNA for efficient antigen presentation and enhanced potency. Regenerative Medicine 6:3, pages 303-318.
Crossref
Crossref
Kenichiro Hasumi, Yukimasa Aoki, Ryuko Watanabe, Kim G. Hankey & Dean L. Mann. (2011) Therapeutic Response in Patients with Advanced Malignancies Treated with Combined Dendritic Cell–Activated T Cell Based Immunotherapy and Intensity–Modulated Radiotherapy. Cancers 3:2, pages 2223-2242.
Crossref
Crossref
John Copier, Mark Bodman-Smith & Angus Dalgleish. (2011) Current status and future applications of cellular therapies for cancer. Immunotherapy 3:4, pages 507-516.
Crossref
Crossref
Jeanette E. Boudreau, Kyle B. Stephenson, Fuan Wang, Ali A. Ashkar, Karen L. Mossman, Laurel L. Lenz, Kenneth L. Rosenthal, Jonathan L. Bramson, Brian D. Lichty & Yonghong Wan. (2011) IL-15 and Type I Interferon Are Required for Activation of Tumoricidal NK Cells by Virus-Infected Dendritic Cells. Cancer Research 71:7, pages 2497-2506.
Crossref
Crossref
. (2011) Current World Literature. Current Opinion in Oncology 23:2, pages 227-234.
Crossref
Crossref
Daniel L. Popkin, John R. Teijaro, Brian M. Sullivan, Shuzo Urata, Sophie Rutschmann, Juan Carlos de la Torre, Stefan Kunz, Bruce Beutler & Michael Oldstone. (2011) Hypomorphic Mutation in the Site-1 Protease Mbtps1 Endows Resistance to Persistent Viral Infection in a Cell-Specific Manner. Cell Host & Microbe 9:3, pages 212-222.
Crossref
Crossref
Philip C Calder. (2010) Lipid-laden dendritic cells fail to function. Cell Research 20:10, pages 1089-1091.
Crossref
Crossref
Joseph F. Murphy. (2010) Trends in Cancer Immunotherapy. Clinical Medicine Insights: Oncology 4, pages CMO.S4795.
Crossref
Crossref
Bo Jin, Tao Sun, Xiao-Hong Yu, Chao-Qun Liu, Ying-Xiang Yang, Ping Lu, Shan-Feng Fu, Hui-Bin Qiu & Anthony E. T. Yeo. (2010) Immunomodulatory Effects of dsRNA and Its Potential as Vaccine Adjuvant. Journal of Biomedicine and Biotechnology 2010, pages 1-17.
Crossref
Crossref